Home The Hard Pursuit of Optimal Vaccination Compliance in Heterogeneous Populations
Article Open Access

The Hard Pursuit of Optimal Vaccination Compliance in Heterogeneous Populations

  • Giorgio Rampa ORCID logo and Margherita Saraceno ORCID logo EMAIL logo
Published/Copyright: December 4, 2024
Become an author with De Gruyter Brill

Abstract

The present model focuses on how people decide to get vaccinated, based on their beliefs and costs and on the public information concerning the disease severity, that in turn depends on the vaccination coverage. This interplay between beliefs and outcomes gives rise to a dynamical learning process, whose steady state is a self-fulfilling equilibrium. Although equilibrium levels of immunization and disease severity do not depend on beliefs, even in equilibrium heterogeneous people interpret the severity/coverage relation in different ways. These differences, together with the structural parameters of the model, have important implications for the stability of the equilibrium, finally impinging on the efficacy of policies aimed at correcting the existing state. In fact, we find that when the equilibrium disease severity is too high and immunization is suboptimal, mandatory vaccination and nudging can be valid options for fighting vaccination hesitancy (while moral suasion looks less effective); in addition, some policy mixes turn out to be very effective. However, given the interaction between beliefs, learning, and policies, the wished policy goal cannot be achieved immediately with precision, due to possible instability of equilibria. This supports the idea that immunization must be encouraged by using mixes of persistent policies.

JEL Classification: D83; K32; I12; I18

1 Introduction

The recent outbreaks of vaccine-preventable illnesses – including the COVID19-pandemic, monkeypox as emerged in Europe in 2022, the reemergence of polio cases in 2022 (virtually eradicated in 1979), recurrent Ebola pandemics in African countries, the jump of measles cases in 2024 (just to mention the most known recent cases) – remind us that immunization policies and related compliance attitudes are indeed a present problem. In 2015, the World Health Organization (WHO hereafter) started considering vaccine hesitancy (the delay in acceptance or refusal of safe vaccines despite their availability) as an increasingly relevant issue.[1] Actually, even for well-known and established immunization programs, including those for protecting children and elders, compliance rates are very heterogeneous depending on the disease, country, target population, and even the flavor of the month. In many European countries, where the immunization coverage was high in the past, many parents and people started to not fully complying with immunization programs (Larson et al. 2018; Tafuri et al. 2014). Finally, in 2019 the WHO has declared vaccine hesitancy one of ten threats to global health.[2]

The reasons why people decide to get vaccinated, or to vaccinate their children, or not, are complex.[3] A considerable public health literature tried to identify various relevant determinants (Dubé et al. 2014; Geoffard and Philipson 1997; MacDonald and SAGE Working Group on Vaccine Hesitancy 2015). Economic studies of vaccination behavior formulated static game-theorical models showing that self-interest would lead to suboptimal vaccination coverage, while subsidies and educational policies would reduce suboptimality (Bauch and Earn 2004; Galvani, Reluga, and Chapman 2007; Shim, Kochin, and Galvani 2009; 2012a). Classical analyses of vaccinating behavior typically predict a single stable equilibrium for any given parameter values. In their systematic literature review, Chang et al. (2020) show that the Nash-equilibrium classical approach still continue to retain its prominence, though network-based models are attracting increasing research interest (Bhattacharyya et al. 2019; Fukuda 2015).

Recent contributions investigated behavioral aspects (Siram, Shah, and Panda 2022), shedding light on the role of beliefs and cognitive biases (Becchetti, Candio, and Salustri 2021; Chen and Stevens 2017), information, fake news, social media (Aquino et al. 2017; Dhaliwal et al. 2020; Jolley and Douglas 2014), (dis)trust in institutions (Yaqub et al. 2014), altruism, herding and social norms (Agranov, Elliott, and Ortoleva 2021; Shim et al. 2012b). In addition, policies regulating specific immunization programs – including mandatory immunization (Gualano et al. 2019), vaccine passports (De Figueiredo, Larson, and Reicher 2021), moral suasion and information campaigns (Bigaard and Franceschi 2021; Honkanen, Keistinen, and Kivela 1996) and nudging (Reñosa et al. 2021) – might affect individual behavior significantly (Becchetti, Candio, and Salustri 2021; Odone et al. 2021; Vrdelja, Učakar, and Kraigher 2020). However, clearcut evidence has not emerged in this sense (Charrier et al. 2022; Gravagna et al. 2020; Vaz et al. 2020).

The present model frames the problem of vaccination hesitancy in a dynamic Bayesian-learning model, where decision-makers belong to two subpopulations that differ in beliefs and costs to get vaccinated. Some previous contributions, too, provided dynamic models. Francis (1997) provided a first model with homogeneous decision-makers (both in respect of beliefs and costs) and a deterministic epidemic function, finally showing that the optimal time-of-vaccination problem must be framed dynamically. Bauch (2005) explained oscillations in the coverage levels by providing a game-theoretic dynamic model. In this herding model, players must estimate their probability of infection, and their decisions are based on disease prevalence and perceived risks. Bhattacharyya and Bauch (2010) prove the relevance of both feedback and feed-forward mechanisms. Coelho and Codeço (2009) acknowledge that dynamic subjective beliefs about the safety of a given vaccine affect adherence to vaccination programs. In their model, the updating process is based on a logarithmically pooling process.

Differently from previous contributions, the present model relies on: (i) heterogeneous decision-makers (who are different in terms of costs and subjective beliefs); (ii) explicit recursive Bayesian learning; (iii) a self-fulfilling equilibrium approach; and (iv) a stability analysis of the equilibria. This allows us to provide some methodological advancements with respect to our previous learning models (Rampa and Saraceno 2016; Rampa and Saraceno 2023).

We show that the equilibrium levels of average vaccination coverage and disease severity are unique and depend only on the structural parameters of the model. On the other hand, there exists an infinity of individual beliefs supporting each single equilibrium: different people interpret the existing situation in different ways, and these beliefs – together with the structural parameters – influence the stability properties of the equilibrium itself. The analytical study of the system, coupled with numerical computations, illustrates that (i) without any intervention, immunization can be low; (ii) nudging and mandatory vaccinations represent a valid approach to reduce average severity, favoring a higher immunization; (iii) there exists an uneasy interaction between people’s learning and immunization decisions and public policies aimed at correcting suboptimal coverage; this typically implies weaker convergence to (or stronger divergence from) the pursued levels of severity and immunization coverage.

2 The Model

2.1 Setup and Assumptions

At the beginning of date 0 (time is discrete), a vaccinable disease outbreak emerges. The Public Health Authority (PHA, hereafter) communicates the fact to the population, clarifying that vaccination can help to reduce the severity: that is, people are publicly invited to take precautions. Define s t as the true severity of the disease (that is, the average cost of its consequences for the population of infected subjects), as can be observed at the end of date t by the PHA. We assume that s t is a Normal random variable with mean α β π t and variance equal to 1, where π t is the immunization coverage. Formally:

s t N α β π t ; 1 , α , β 0,1 .

Randomness is due to different factors: individual genetic predisposition, exposure, precautions, etc. The normality assumption seems reasonable, besides allowing for better tractability of the model. Concerning the linear relation αβπ t , observe that it refers to the mean of the distribution of s t . Although linearity may appear simplistic, it allows us to keep the analysis tractable, while capturing the relevant elements of the relation between average severity and immunization coverage (see the comment in footnote 10 below). The unit-variance assumption is without loss of generality. α and β are the structural parameters of the model, and both are unknown.

At the end of each date t, the PHA, though not knowing α and β,[4] observes the average severity s t and the overall immunization coverage π t . These observations are communicated to the population.

The general population is composed of two components: subpopulation P is averagely “prompt” to get vaccinated, while subpopulation H is more “hesitant”. The weight of subpopulation P is γ and the weight of subpopulation H is 1−γ. Population promptness/hesitancy is endogenous to the model and is due both to individual costs to get vaccinated and to beliefs.

In particular, individual j belonging to subpopulation i bears an individual cost to get vaccinated equal to c j,i that includes both costs of immunization and other monetary and non-monetary costs, depending on individual risk aversion, fear of side effects of vaccination, etc. We assume that c j,i is uniformly distributed within each subpopulation:

c j , i U 0 , θ i i = P , H 0 < θ P < θ H

The clause θ P < θ H indicates that people in subpopulation P bear a lower maximum cost to be vaccinated: therefore, we expect that – ceteris paribus – subpopulation P displays a greater readiness to get vaccinated.

When the outbreak emerges and this is communicated by the PHA, people correctly assume that the severity of the disease is a random variable N s i , t e , 1 , with s i , t e depending on the immunization coverage. However, since the true relation between s t and π t is unknown, each subpopulation i shares a common subjective prior on the structural parameters α and β, such that s i , t e = α i , t β i , t π i , t e where π i , t e is the expected immunization coverage.

Formally, the prior of subpopulation i on the structural parameters α and β is a Normal bivariate; the mean and precision[5] of this subjective distribution at date t are, respectively, the following vector z i,t and the symmetric precision matrix H i,t :

z i , t = α i , t β i , t H i , t = η i , α , t η i , α β , t η i , α β , t η i , β , t i = P , H .

As for date t = 0, we assume α i,0 > 0, η i,α,0 > 0, η i,β,0 > 0, η i,αβ,0 = 0. In general, we define the parameters α i,t and β i,t as the mean hyperparameters, and η i , α β , t as the precision hyperparameters of the model. At the beginning of each date, subpopulation i expects π i , t e = π t 1 ,[6] so that the expected severity is s i , t e = α i , t β i , t π t 1 .

At the end of date t, once immunization decisions have been taken, people learn s t and π t from the PHA and update their prior along Bayesian lines.[7] The posterior at date t becomes the prior of date t + 1: see Figure 1.

Figure 1: 
Timing of the model on date t.
Figure 1:

Timing of the model on date t.

2.2 The Decision to Get Vaccinated: Immunization, Severity, and Learning

Given their costs and conjectures, people must decide whether to get vaccinated on each date, because immunization is temporary. Individuals make this decision by comparing the expected consequences (severity) of the disease and their own cost of being vaccinated. Individual j belonging to population j decides to get vaccinated if and only if

c j , i < s i , t e = α i , t β i , t π t 1

The expected disease severity s i , t e is common to all individuals of each subpopulation and depends on the overall expected coverage (embedding all individuals’ decisions); the latter is computed adaptively ( π i , t e = π t 1 ). At the start of t = 0, since no immunization decision has yet been taken, π t−1is equal to 0 and, therefore, in order to make decisions during t = 0, the expected severity s i , t e is set equal to α i,t .

Given the uniform distribution of individual costs, the share of each subpopulation deciding to get immunized is:

π i , t = α i , t β i , t π t 1 θ i 0 α i , t β i , t π t 1 θ i 1 1 α i , t β i , t π t 1 θ i > 1 0 α i , t β i , t π t 1 θ i < 0 , i = P , H

The vaccination coverage of subpopulation i is obviously inversely related to θ i : hence, as expected, the vaccination coverage in population P is higher than in population H.

The overall immunization coverage on date t is the average of the two subpopulations:

(1) π t = γ θ P α P , t β P , t π t 1 + 1 γ θ H α H , t β H , t π t 1

In particular, at t = 0 we have π 0 = γ θ P α P , 0 + 1 γ θ H α H , 0 .

Given the immunization coverage π t , the expected value of severity on period t is:

(2) s t = α β γ θ P α P , t β P , t π t 1 + 1 γ θ H α H , t β H , t π t 1

By inspecting (1) and (2), we observe that the overall immunization coverage on a given date t depends on both structural parameters and hyper-parameters. Not surprisingly, we conclude that the immunization coverage depends (i) positively on the expected severities without any immunization coverage as conjectured by both subpopulations (α i,t ); (ii) negatively on the effectiveness of vaccine as conjectured by both subpopulations (β i,t ); (iii) positively on the weight γ of the prompt-to-be-vaccinated subpopulation; (iv) negatively on the maximum individual costs to get vaccinated (θ i ).

Once vaccination decisions are taken and π t and s t are observed and communicated by the PHA, the subpopulations update their priors. As shown in the Appendix, by using the previous definitions of z i,t and H i,t , and defining the vector x t = 1 π t , the posterior at the end of date t (corresponding to the prior at the beginning of date t + 1) is:

(3) z i , t + 1 = z i , t + H i , t + x t x t 1 x t e i , t

In (3) we define e i , t = s t x t z i , t = α β γ θ P α P , t β P , t π t 1 + 1 γ θ H α H , t β H , t π t 1 α i , t + β i , t π t : the term e i,t measures the forecasting error made by each subpopulation i at date t. Therefore, the updated z i,t+1 turns out to be equal to z i,t , corrected by a term containing the forecasting error “deflated” by the inverse of the posterior precision matrix H i , t + 1 = H i , t + x t x t . The precision matrix grows over time (in the sense of the positive-definite matrix ordering, see the Appendix), so that its inverse decreases in time: therefore, the updating process becomes increasingly slower. Expression (3) also shows that when initial precisions (H i,0) are very high, the updating process is very sluggish right from the start. When this happens, communications from the PHA have a small impact on the updated conjectures right from the beginning.

The forecasting errors e i,t , entering the recursive adjustment of priors, depend negatively on α i,t (the higher α i,t , the higher the expected severity), and positively on β i,t (the higher β i,t , the lower the expected severity). The impact of priors on the forecasting error clearly depends also on the structural parameters of the model.

Combining equations (1)(3) recursively, we can simulate the subpopulations’ immunization coverages (and, of course, the average severities) at different dates, starting from given initial conjectures. By inspecting Figures 2 and 3, that illustrate the evolution of immunization coverage in time for given parameters, we observe that the model captures some relevant effects that are commonly associated with vaccination hesitancy.

Figure 2: 
Vaccination coverage: t from 0 to 20 – impact of different structural parameters.
Figure 2:

Vaccination coverage: t from 0 to 20 – impact of different structural parameters.

Figure 3: 
Vaccination coverage: t from 0 to 20 – impact of different initial hyperparameters.
Figure 3:

Vaccination coverage: t from 0 to 20 – impact of different initial hyperparameters.

First, given that the actual average severity depends on the overall coverage, individuals who opt for vaccination suffer from a negative “externality” due to the choice of those who do not opt for immunization. Vice versa, people who prefer avoiding vaccination benefit from the positive externality of a high overall coverage (low average severity); the latter attitude can be seen as freeriding.[8] These external effects operate both among individuals within each of the two subpopulations, and between the two subpopulations.

Second, an overshooting effect can be detected with respect to the long-run coverage (that, as clarified in Section 3, does not necessarily correspond to a socially optimal coverage). In fact, during the first dates, when adjustments are large because learning has a relevant impact, the vaccination coverage temporarily overreacts to changes in observed levels of severity/coverage. Indeed, we see from expression (3) that changes in beliefs, z i,t+1z i,t , move in the same direction as the forecasting error e i,t , meaning that subpopulation’s mean hyperparameters – and hence subpopulation’s vaccination coverages – negatively depend on their past values.

Third, we observe a sort of herding effect due to learning: each subpopulation adjusts its behavior accounting for the overall immunization coverage and the related average severity, partially induced by the other subpopulation’s behavior.

Furthermore, in Figure 3 we observe that the initial precision hyperparameters determine the pace of convergence, because they determine the readiness of the updating process. In particular, low precisions allow faster convergence (3A vs 3B). The differences in initial subpopulations’ conjectures on α and β matter as well: very distant priors imply stronger oscillations and a longer-lasting overshooting (3C vs 3D).

2.3 Self-Fulfilling Equilibria and their Dynamic Stability

In order to analyze the impact of changes in structural parameters, also in terms of dynamic stability, we introduce a proper concept of equilibrium. Define a self-fulfilling equilibrium [9] (SE, hereafter) as a situation in which the subpopulations’ priors are correct at the information set that is reached in the equilibrium position, but not necessarily correct out of equilibrium. Consequently, a SE is reached when people guess (locally) the average severity given the existing vaccination coverage, and both subpopulations have no reason to modify their beliefs and the related vaccination decisions. This means that a stationary state of the dynamical learning process has been reached, and no further change will take place. Recalling that s t is a random variable, the reasoning below is cast in expected-value terms, that is, for an SE we require s i , t e = E s t . We underline that a SE has nothing to do with social optimality (see Section 3).

The SE condition can be represented by the following system (time subscripts are omitted since variables stay constant in equilibrium):

(4) α P β P π = α β π α H β H π = α β π π = γ θ P α P β P π + 1 γ θ H α H β H π

From (4) we obtain the SE values of both the vaccination coverage π SE and the related average severity s SE (5), and the SE conjectures of the two subpopulations (6).

(5) π SE = γ θ P + 1 γ θ H α 1 + γ θ P + 1 γ θ H β ; s SE = α β γ θ P + 1 γ θ H 1 + γ θ P + 1 γ θ H β α

(6) β SE , i = β + α SE , i α π SE i = P , H

A few comments are in order. First, as can be verified by looking at (5), the SE coverage-severity couple is unique, and depends only the on structural parameters: the precise location in the stationary state of π SE and s SE does not depend on the subpopulations’ priors. The structural parameters monotonically affect the SE coverage and severity as expected: the SE coverage is increasing in α and γ, while being decreasing in β and θ i ; the SE severity in increasing in α and θ i , and is decreasing in β and γ (see the derivatives provided in the Appendix).

Second, by looking at (6), we conclude that there exist a doubly-infinite set of quadruplets of mean hyperparameters that are compatible with the SE. This infinity is easily interpreted from the geometrical point of view. Indeed, as illustrated in Figure 4, it consists of all possible intersections between the true average severity function s = αβπ and the average severities as conjectured by the two subpopulations s SE = α SE,i β SE,i π.[10] Given any discretional α i , the hyperparameter β i must satisfy (6), and vice versa. From the learning perspective, the infinity of possible SE priors implies that the subpopulations end up, in equilibrium, with (possibly very) different interpretations of the stationary state: even if guessing the true values of immunization coverage and average severity, subpopulations envisage different relations between the two variables. Therefore, if a shock hit the system, they would expect (possibly very) different consequences: a subpopulation could even believe that vaccination is noxious (β SE,i < 0, third graph in Figure 4).

Figure 4: 
Three possible SEs for given structural parameters (α = 0.9, β = 0.5, γ = 0.8, θ

P
 = 1, θ

H
 = 2).
Figure 4:

Three possible SEs for given structural parameters (α = 0.9, β = 0.5, γ = 0.8, θ P = 1, θ H = 2).

Notably, the existence of a multiplicity of possible equilibrium priors (equilibrium hyperparameters) is proved despite the unicity of the equilibrium severity-coverage couple. The location of equilibrium, as seen above, depends only on the structural parameters of the model; however, its stability features crucially depend also on the priors of the populations, as we are going to discuss.

Different structural parameters are associated with different SEs; therefore, a shock affecting those parameters displaces the system from the pre-existing SE position. However, after a shock, people observe an unexpected change, so that a new learning process starts. As a consequence, the system may converge towards the new SE or, otherwise, it may diverge from it. In order to study the dynamic properties of the new SE, we consider the eigenvalues of the Jacobian matrix of the dynamical system evaluated at the new SE (details provided in the Appendix). The analytical study of the relation between the eigenvalues and the values of structural parameter turn out to be quite difficult (due to the highly complex dependence of the former on the latter), so that we had to resort to numerical computations in order to obtain the time of convergence (TOC, hereafter) and the period of oscillation associated with different parameter combinations.[11]

Concerning the period of oscillation, in most cases it is equal to 2, meaning that there are alternating “up and down” movements towards the SE (as observed in Figures 2 and 3). In very few cases, the period is a number greater than 2, implying that movements around the SE are slower (they are waves of lower frequency): therefore, we do not further comment on the periods of oscillation.

On the other side, the TOC is quite sensitive to parameter changes. Consider that a positive TOC associated with a SE indicates how rapidly the variables converge to that SE if they are slightly displaced from it. On the contrary, a negative TOC means divergence (the system would converge if it moved backwards in time). A lower positive TOC means faster convergence, while a lower negative TOC indicates slower divergence.

The TOC has important consequences for the promptness of public policies in achieving the desired new level of severity/coverage (see Section 3). In fact, if a particular equilibrium is aimed at by the PHA by means of some intervention, a longer TOC associated with that equilibrium implies that reaching the objective is harder, and presumably more costly for society. This aspect must be kept logically distinct from the overshooting oscillations discussed in Section 2.2, that of course are socially costly as well since severity and coverage are not at their optimal levels.

In Figure 5 we plot the stability of SEs, measured by the TOC, against different parameter values. This is done for different scenarios (different lines in the same graph). We display a baseline scenario,[12] plus some variations thereof: the variations consist in modifying a single parameter, keeping constant the remaining ones. Upswinging lines correspond either to a decreasing rate of convergence (if located in the positive zone), or to an increasing rate of convergence (in the negative zone). The first five graphs of Figure 5 refer to the effects of structural parameters, and the last graph refers to the effects of the precision hyperparameters of subpopulation P:[13] recall that, while the location of SEs does not depend on the value of hyperparameters, it does depend on structural parameters.

Figure 5: 
Time of convergence (TOC) against different parameters, under various scenarios.
Figure 5:

Time of convergence (TOC) against different parameters, under various scenarios.

Regarding the first five graphs in Figure 5, we see that increases either in α or in θ i lead to higher stability or lower instability (decreasing TOC) in all possible scenarios.[14] Vice versa, higher values of β and γ induce lower stability or higher instability in all scenarios. On the other hand, the last graph in Figure 5 shows what we know from the analysis of Section 2: higher initial precisions (matrices H i,0) cause a more sluggish learning rate and a longer convergence rate.

Therefore, we are able to conclude that changes in structural parameters resulting in a lower SE average severity (namely, higher β or γ, and lower θ i or α) tend to push in the direction of slower convergence or faster divergence. In fact, any change/intervention that, starting from an existing SE, reduces the true mean severity s causes a negative forecasting error of subpopulations. Hence, the learning mechanism forces the two subpopulations to reduce both α i and β i (see expression (3)): this may give rise to a greater difference in steepness between the conjectured and the true πs relation. Therefore, there can result an initial lower stability or greater instability, as it happens in many Cobweb and adaptive expectations models (Ezekiel 1938; Gandolfo 1980; Nerlove 1958 chapter 4, Hommes 1994; Hommes et al. 2007).

An observation is in order. Our stability analysis and the above numerical experiments are implemented by fixing the precision hyperparameters, so that we can appreciate the characteristics of the dynamical paths only in the very first periods after a displacement from a SE. On the other side, we know from Section 2 that precisions actually increase in time: this (as shown also by the last graph in Figure 5) dampens the oscillations after a number of periods. Therefore, paths that are initially unstable will not diverge indefinitely, nor stable ones will converge rapidly: in finite time, they could approach some non-equilibrium position surrounding a SE, or could be captured by the basin of attraction of another stable SE.

Concluding, when structural parameters change, not only the system shifts towards new SEs, but, in addition, the latter are characterized by different stability properties. In particular, some changes might lead to a longer convergence time/shorter divergence time. This must be very clear to the policymakers intervening on parameters to the end of reducing the average severity of a vaccinable disease. Each intervention should be carefully evaluated not only for its capacity to achieve a new desirable SE, but also in terms of its dynamic effects.

3 Policies to Promote (Optimal) Severity Reduction

Reducing the average severity of a disease is often considered as a major public health policy target. Clearly, a trade-off exists between social benefits of reducing s t (milder consequences for individuals, lower impact on hospitals, healthcare systems and social security systems, etc.) and social costs to achieve this reduction (health assistance and social security costs to support infected people, costs of vaccine manufacture, costs of vaccine side-effects, etc.). The PHA is expected to define its policy target in terms of a socially optimal average severity, derived by optimizing some standard social cost-benefit function. Generally, the socially optimal average severity is higher than zero, due to the social costs, and not too high, due to social benefits.[15]

The existing SE severity, that depends on the real structural parameters, can differ from the socially optimal average severity, and can be greater or smaller than the latter. The PHA interested in aligning the s SE to the socially optimal average severity must be aware that only interventions affecting the structural parameters can be effective to achieve the purpose, even if the PHA might not, and in general does not, know these parameters precisely. In addition, as seen in the previous Section, the PHA must consider that each specific policy intervention on structural parameters will have a different impact in terms of effectiveness and of the time dynamics needed to achieve the policy goal (TOC).

Since in most cases the PHA is called to intervene to reduce the average severity s SE that is higher than the socially optimal one, we focus on policies working in that direction, namely favoring a lower average severity (Ozawa et al. 2016). Those who are interested in policies aimed at letting s SE increase (because it is lower than the socially optimal severity) can simply reverse our reasoning.

In what follows we compare the impact of nudging, mandatory vaccination, and moral suasion policies. The comparison among policies will be based on numerical computations, reported graphically, and in terms of elasticities. Note that the implementation of each policy typically entails specific fixed costs that, though relevant, do not determine the socially optimal level of severity at the margin. E.g., the costs of setting accessible immunization services or arranging an appealing information campaign aimed at finally reducing the disease average severity, do not depend on the size of severity reduction and can be simply seen as an additional fixed cost for the PHA.

3.1 Nudging, Subsidies, and Mandatory Vaccination

In order to favor vaccination compliance, resources might be invested in subsidizing and/or nudging individual decisions to get vaccinated. Public vaccination campaigns involve nudging, besides some forms of subsidies. For example: (a) people (or specific categories like newborns, kids, elders, fragile people, etc.) can be vaccinated for free or for a capped price; (b) individuals are invited to comply with a vaccinal agenda; (c) vaccinations are facilitated, being provided by general practitioners/pediatricians, local vaccination centers, or even the pharmacies.[16] In general, most of the PHA actions aiming at reducing vaccination hesitancy and favoring higher vaccination coverages are based on a significant reduction of individual monetary and non-monetary costs to get vaccinated. According to our model, this policy can be seen as a shrinking of the individual cost distributions. Recall that when s SE is too high with respect to the socially optimal severity (and, then, π SE is suboptimal), the PHA can reduce s SE by increasing π SE thanks to reductions in θ i , i = P, H (see Section 2.3). Note that green-passes (Campanozzi, Tambone, and Ciccozzi 2022) and other immunization passports (Sharun et al. 2021) can be modelled as negative nudging mechanisms that, by increasing the individual cost of non-compliance, in fact result in lower θ i .

In many countries, some vaccinations are mandatory, and noncompliance is variously sanctioned. For instance, people who do not comply with mandatory infant vaccinations can be sanctioned with monetary sanctions and children cannot attend schools. During the COVID 19 pandemic, several countries introduced mandatory vaccinations, at least for some categories of people. In our model, we can assume that a fixed penalty S > 0 is certainly paid by those who do not comply with mandatory vaccinations. In this case, the individual j of subpopulation i decides to get vaccinated on date t if and only if α i,t β i,t π t−1 > c j,i S. Reconsidering the passages provided in Section 2.2, we conclude that when vaccination noncompliance is punished with a sanction, coverage increases. Repeating those passages, we obtain an equilibrium immunization coverage with sanction π SE , S = γ θ P S + 1 γ θ H S α 1 + γ θ P S + 1 γ θ H S β , which is indeed greater than π SE without sanctions. The SE average severity s SE,S = αβπ SE,S decreases consequently. A punishment system can allow the PHA to pursue a lower disease average severity at relatively low costs (the costs of implementing the sanction system).

The introduction of a uniform sanction results in a reduction of the relevant cost thresholds to decide to comply or not, similarly to the case of nudging. In spite of this similarity, there is a significant difference between the two. The sanction, being the same for all individuals within the two subpopulations, has a higher relative impact on subpopulation P in terms of the number of new people who are induced to get vaccinated; in addition, it has a higher relative impact for the group of individuals within each subpopulation who are characterized by a low c i . Clearly, a moderate sanction cannot convince people who are characterized by very high individual cost to get vaccinated.

3.2 Educational Campaign/Moral Suasion

A further strategy to favor vaccination compliance is promoting information or setting up educational campaigns to encourage or persuade people to vaccinate. These interventions are typically targeted to specific subpopulations – here H, the hesitant one. A successful policy might move some individuals from subpopulation H to subpopulation P, finally increasing γ. By increasing γ, s SE decreases (see Section 2.3), once again favoring the realignment of SE levels to the socially optimal values.

3.3 Comparison among Policies for Reasonable Scenarios

Here, we will compare the effects of policies considering different scenarios, characterized as follows.

The baseline scenario (α = 0.9, β = 0.5, θ P = 1, θ H = 2, γ = 0.8) is such that disease displays a relatively high zero-vaccination average severity, and vaccination is fairly effective. The largest part of the population is endowed with relatively low individual costs (subpopulation P), while those with higher individual costs (subpopulation H) are a minority.

Besides the baseline scenario, we consider a low α scenario (α = 0.5) that differs from the former because the disease is less severe, independently of the vaccination coverage; a high β scenario (β = 1) that differs from the baseline scenario because the vaccination is significantly more effective; a similar costs scenario (θ H = 1.1) that deviates from the baseline scenario because the two subpopulations differ only slightly in terms of individual costs; and a low γ scenario (γ = 0.2) that differs from the baseline scenario because now the largest part of the population is subpopulation H.

Changes in populations’ hyperparameters are not explicitly considered here, since they affect only the dynamical features of SEs (TOC), already analyzed in Section 2, while do not affect SE coverage and severity levels.

Consider first single-parameter policies (nudging on population P, nudging on subpopulation H, and moral suasion aimed at increasing γ). By comparing the various graphs in Figure 6 (especially slopes and heights), we can observe the following facts:

  1. The effects on the policy target that are associated with the nudging on H people and moral suasion are significantly weaker than those induced by the nudging on P people. In fact, by reducing θ H from 2 to 1, the SE severity moves from approx. 0.65 to approx. 0.35. By increasing γ from 0 to 1, the SE severity moves from approx. 0.72 to approx. 0.35. Something similar happens looking at the SE coverages. Focusing instead on θ P , we observe that by decreasing it from 1 to 0, the SE severity moves form approx. 0.7 to 0.0. Analogously, the SE coverage increases from 0.3 to 1.0.

  2. Nudging on subpopulation P allows to rapidly achieve minimum SE severity (maximum coverage), because these people are particularly prompt to get vaccinated (due to their individual costs) and represent the largest part of the population. In this respect, the similar costs scenario approximately overlaps the baseline scenario, while under the low γ scenario nudging is extremely effective for very low values of θ P while becoming less effective for higher values of θ P (the “Low γ” line becomes flatter).

  3. Nudging on subpopulation H is significantly less effective (lines are almost flat), because individuals H are less prompt to get vaccinated due to their costs and represent the minority of the population. Actually, when we consider the low γ scenario, nudging of subpopulation H starts being effective (higher slope of the “Low γ” lines) because a larger part of the population benefits from that policy.

  4. Moral suasion has a moderate impact on the policy targets (weakly sloping lines), and this impact tends to vanish under the similar costs scenario. Indeed, intervening on individual characteristics (in order to move part of population from H to P) might be poorly effective when (individual costs of) the two subpopulations are not too polarized.

  5. For all policies, the SE severity under the low α scenario and under the high β scenario is systematically lower than under the other scenarios (the “Low α” and “High β” lines stay in the lower part of the graphs and are flatter), because such scenarios are already more favorable to a lower SE severity, though they are associated with a systematically lower vaccination coverage (see the relevant derivatives provided in the Appendix).

Figure 6: 
Nudging on Ps, nudging on Hs, and moral suasion on SE: severity and immunization coverage for various scenarios.
Figure 6:

Nudging on Ps, nudging on Hs, and moral suasion on SE: severity and immunization coverage for various scenarios.

In order to appreciate the relative impact of the policies, including mandatory vaccination with sanction and other policy mixes, it is interesting to compare the average elasticity of the policy target (SE severity/immunization coverage) with respect to each policy parameter.

The elasticity is the ratio of the percentage variation in the policy target to the percentage variation in the policy parameter, evaluated at a particular value of the parameter. The average elasticity is computed over twenty evenly spaced values of each policy parameter, from its minimum to its maximum, as it appears in the horizontal axes of Figure 6. With regard to the policy mixes involving two policy parameters, the overall elasticity is computed as the mean of the average elasticities associated with each policy parameter. The numbers, provided in Table 1 below, describe the percentage average variation in the policy target due to an overall one per cent variation (increase or decrease, depending on the policy) in the policy parameters.

Table 1:

Average elasticities of s SE and πSE with respect to various policies (1 per cent change in the policy parameter).

Elastic. of A. nudging on P Δθ P = −1 % B. nudging on H Δθ H = −1 % C. moral suasion Δγ = +1 % D. sanction Δ θ i S = 1 % A. – C. mix Δθ P = −Δγ = −0.5 % B. – C. mix Δθ H = −Δγ = −0.5 %
Baseline s SE −0.433 −0.044 −0.088 −0.478 −0.260 −0.066
π SE 0.498 0.095 0.216 0.593 0.357 0.155
High β (β = 1) s SE −0.579 −0.067 −0.136 −0.647 −0.358 −0.203
π SE 0.352 0.072 0.168 0.424 0.260 0.119
Similar costs (θ H = 1.1) s SE −0.425 −0.015 −0.220
π SE 0.458 0.032 0.245
Low γ (γ = 0.2) s SE −0.161 −0.423 −0.584
π SE 0.334 0.450 0.784
  1. The Low α scenario is omitted because the elasticities under that scenario are equal to those of the Baseline. This happens because α only affects the intercept of the s SEπ SE relation.

The average elasticities confirm what we already observed in the graphs: the nudging on subpopulation P is more effective than the nudging on subpopulation H, at least as long as the former is preponderant. When the latter becomes preponderant (see the low γ scenario), the nudging on subpopulation H is effective, though the impact is smaller than when the preponderant subpopulation is P and it is nudged (−0.423 vs −0.433).

When vaccines are relatively more effective (high β scenario), all the policies have a greater impact on severity reduction, though having a smaller impact on the increase of coverage (there exists a substitution effect between vaccine effectiveness and immunization coverage).

Moral suasion per se has a significantly smaller impact on the policy targets than nudging. However, it can be successfully used joint with nudging (see the comment below).

Mandatory vaccination, here, is intended as a situation where those who do not comply with the immunization obligation are sanctioned. The elasticities are computed for a 1 per cent decrease of the term θ i S . This policy looks effective under all scenarios. The same result could be achieved through a subsidy of S to both subpopulations. Obviously, the two solutions are different in redistributive terms, because in the former case those who do not comply pay for the sanction, while in the latter case those who get vaccinated are subsidized.

In the case of mixes of moral suasion and nudging, we observe that the former weakens the nudging on subpopulation P while strengthening the nudging on subpopulation H. This confirms the greater effectiveness of nudging on the promptest subpopulation.

In summary, mandatory immunization (with sanctions) appears as an easy way to promote vaccination compliance, finally resulting in a significant reduction of the SE severity. However, other policy mixes appear to be effective as well. In particular, this happens for moral suasion joint with nudging in favor of the largest component of the population. For these reasons, countries must guarantee updated vaccinal agenda, granting both easy access to immunization (nudging) and sanctions in the case of non-compliance.

Concerning the implications of the various policies in terms of dynamics, we learnt from our model (Section 2.3 and Figure 5) that the more effective is the policy in reducing the average severity, the higher is the TOC. This means that effective policies induce weaker stability (or even stronger instability) of the associated SE, at least initially. Hence, the system might eventually converge to a position that is not the one projected by the PHA. This has important policy implications in terms of greater effort that the PHA must exert in order to reach its objectives. The model, therefore, sheds light on an uneasy interaction between policies and private beliefs/costs, learning, and the related behavior. Our arguments suggest that the PHA should be very pragmatic when intervening and should persist in the implementation of its policies.

Finally, the model seems to fit quite well two relevant aspects of immunization behavior that can be observed in reality. First, the interaction between scientific evidence (the observed severity) and people conjectures/learning/decisions translates into the existence of subsequent phases of oscillatory immunization behavior (D’Onofrio and Manfredi 2020; Duclos et al. 2009; Lanza-León, Cantarero-Prieto, and Pascual-Sáez 2024; Mantel and Cherian 2020). Second, the evidence that the same policies can result in different impacts depending on the country can be explained by the fact that people in different communities are endowed with different beliefs and costs (González-Block et al. 2020; Odone et al. 2021; Paul and Loer 2019; Privor- Dumm et al. 2020; Vakili et al. 2015).

4 Conclusions

The present model contributes to the understanding of how uncertain people decide to get vaccinated, based on their heterogeneous conjectures and their individual costs of getting vaccinated. As showed, absent any policy intervention, immunization coverage tends to be low, and the dynamics over time shows the relevance of overshooting effects and herd effect induced by learning. Furthermore, external effects emerge, due to the heterogeneity of both individuals and subpopulations.

Using the notion of self-fulfilling equilibrium (SE), we prove the uniqueness of the equilibrium severity and the vaccination coverage, that depend only on the structural parameters of the model. This allows to understand that a Public Health Authority interested in reducing the SE average severity of a vaccinable disease must intervene on the structural parameters and not on individual priors. However, a SE is compatible with an infinity of possible subpopulation beliefs: the two subpopulations keep envisaging different relations between severity and vaccination coverage. Beliefs and their precisions, in fact, though not determining the SE severity/immunization coverage, are very relevant for the SE’s stability features.

By analyzing different PHA interventions, we put forward some general conclusions. Nudging, on the one hand, and mandatory vaccinations with sanctions for those who do not comply, on the other hand, represent a valid approach to reduce the average severity of a disease by favoring larger vaccination coverage. Mixing nudging and sanction can be particularly suitable. When promoted without any other type of intervention, information campaigns aimed at reducing the weight of incorrigible hesitant, though helpful in theory, are not very effective.

By intervening on structural parameters, the PHA should account for the dynamical effects induced by policies. Policies represent exogenous shocks moving the system from a previous SE towards another possible one; the related dynamical path should be carefully considered. In fact, policies aimed at reducing the disease severity could increase instability, especially in the first periods. In other words, policies can be used to pursue target levels of severity/immunization coverage; however, reaching the exact policy goal might be difficult. For these reasons, PHA policies pursuing the reduction of disease severity through actions on structural parameters must be persistent and constantly supported.


Corresponding author: Margherita Saraceno, Department of Law, University of Pavia, Corso Strada Nuova 65, 27100 Pavia, Italy, E-mail: 

Acknowledgments

We are grateful to Alessandro Spelta, the editor Francesco Parisi, and two anonymous referees for their very helpful suggestions. We also thank participants at the EALE Annual Conference (2023), the Regulation Research Conference 2023 in Regensburg, and the ECONtribute Law & Econ Workshop at the University of Bonn (2024). All errors are our own.

  1. Competing interests: None declared.

Appendix

A.1 Bayesian Learning

Recall that z i , t α i , t β i , t . Define then the vector x t 1 π t , that is, the vector of the “regressors” of the equation s i , t e = α i , t β i , t π t that people would conjecture after being informed of π t , given their previous prior. Following De Groot (1970, chapter 11), under our assumptions, the updated hyper-parameters are as follows:

(1A) z i , t + 1 = H i , t + x t x t 1 H i , t z i , t + x t s t and H i , t + 1 = H i , t + x t x t , i = P , H

Observe that the precision matrix H i,t grows in time in the sense of positive definite matrix ordering. In fact, H i,0 is positive definite by assumption and the outer product x t x t is semi-definite positive, ∀t even though x t includes the negative term −π t .

After some simple passages, the first expression translates into

(2A) z i , t + 1 = z i , t + H i , t + x t x t 1 x t s t x t z i , t

The final parenthesis contains the forecasting error for subpopulation i, e i , t s t x t z i , t , given that s t is the true average severity at the end of time t, communicated by the PHA together with the actual π t , while x t z i , t is the one that would be computed by population i on the basis of its prior and of the actual π t .

A.2 SE Derivatives with Respect to the Structural Parameters

π SE α = γ θ P + 1 γ θ H 1 + β γ θ P + 1 γ θ H > 0 , s SE α = 1 β γ θ P + 1 γ θ H 1 + β γ θ P + 1 γ θ H > 0 ;

π SE β = α γ θ P + 1 γ θ H 2 1 + β γ θ P + 1 γ θ H 2 < 0 , s SE β = α γ θ P + 1 γ θ H 1 + β γ θ P + 1 γ θ H + α β γ θ P + 1 γ θ H 2 1 + β γ θ P + 1 γ θ H 2 < 0 ;

π SE θ P = α γ θ P 2 1 + β γ θ P + 1 γ θ H β + α β γ γ θ P + 1 γ θ H θ P 2 1 + β γ θ P + 1 γ θ H 2 < 0 , π SE θ H = α 1 γ θ H 2 1 + β γ θ P + 1 γ θ H + α β ( 1 γ ) γ θ P + 1 γ θ H θ H 2 1 + β γ θ P + 1 γ θ H 2 < 0 ;

s S E θ i = β π SE θ i > 0 ;

π SE γ = α 1 θ P 1 θ H 1 + β γ θ P + 1 γ θ H α β 1 θ P 1 θ H γ θ P + 1 γ θ H 1 + β γ θ P + 1 γ θ H 2 > 0 because θ H > θ P , s SE γ = β π SE γ < 0 .

A.3 Dynamic Stability of SE

We wish to understand whether and how, starting from a certain SE position, the system converges towards another SE or, otherwise, it diverges after a shock like a policy affecting one of the structural parameters of the system. To this end we examine the stability properties of our discrete-time dynamical system. The dynamical system whose stability properties we wish to examine is defined by equations (2A), coupled with expression (1) in the main text and with the formulation of the forecasting errors. Recall that we reason in expected-value terms. The following five variables are involved: α P,t , β P,t , α H,t , β H,t , π t . Defining the vector y t α P , t , β P , t , α H , t , β H , t , π t , we have a formal definition of our five-dimensional and non-linear system of difference equations to be analyzed, namely:

(3A) y t = F y t 1

We propose to study the local stability of SEs. Following Gandolfo (1980), we compute then the Jacobian matrix of system, evaluated at a SE, and study the eigenvalues of this matrix. The characteristics of the eigenvalues determine how the variables move after a tiny displacement from the SE at which the Jacobian and its eigenvalues are evaluated. Our strategy is to evaluate the local dynamical properties of a SE keeping precisions constant at their initial values: in other terms, we evaluate the potential trajectories of variables in the very first periods after a shock, well knowing that these trajectories will tend to relax in the subsequent periods.

The relevant information that can be derived from the eigenvalues of the Jacobian matrix are the following:

  • (a) the presence of a positive eigenvalue means that there is a component of the out-of-equilibrium trajectory that is monotonic with respect to the SE;

  • (b) the presence of a negative eigenvalue implies a two-period oscillation around the SE;

  • (c) the presence of a couple of complex-conjugate eigenvalues implies a longer-period oscillation (smoother waves), whose frequency depends on the argument of the complex eigenvalues;

  • (d) the modulus of an eigenvalue determines whether the movements are convergent or divergent with respect to the SE: a modulus lower (resp. greater) than one means convergence, or stability (resp. divergence, or instability).

The 5 × 5 Jacobian of system, computed at a SE, is:

(4A) J 5 = J 1,1 J 1,2 J 1,3 J 1,4 δ P t η P , β β γ θ P β P + β 1 γ θ H β H β P J 2,1 J 2,2 J 2,3 J 2,4 δ P t η P , α β γ θ P β P + β 1 γ θ H β H β P π J 3,1 J 3,2 J 3,3 J 3,4 δ H t η H , β β γ θ P β P + β 1 γ θ H β H β H J 4,1 J 4,2 J 4,3 J 4,4 δ H t η H , α β γ θ P β P + β 1 γ θ H β H β H π γ θ P Σ j = 1 4 J j , 1 γ θ P π Σ j = 1 4 J j , 2 1 γ θ B Σ j = 1 4 J j , 3 1 γ θ B π Σ j = 1 4 J j , 4 β H 1 γ θ H + β P γ θ P

where δ i t 1 η i , α η i , β t + η i , α π 2 + η i , β , i = P , H . The terms J 1,1 J 1,2 J 1,3 J 1,4 J 2,1 J 2,2 J 2,3 J 2,4 J 3,1 J 3,2 J 3,3 J 3,4 J 4,1 J 4,2 J 4,3 J 4,4 form the matrix J 4, defined as follows

J 4 = I 4 + 1 t δ P t η P , β θ P + β γ θ P δ P t η P , β θ P + β γ θ P π δ P t η P , β β 1 γ θ H δ P t η P , β β 1 γ θ H π δ P t η P , α π θ P + β γ θ P δ P t η P , α θ P + β γ θ P π 2 δ P t η P , α π β 1 γ θ H δ P t η P , α β 1 γ θ H π 2 δ H t η H , β β γ θ P δ H t η H , β β γ θ P π δ H t η H , β θ H + β 1 γ θ H δ H t η H , β θ H + β 1 γ θ H π δ H t η H , α π β γ θ P δ H t η H , α β γ θ P π 2 δ H t η H , α π θ H + β 1 γ θ H δ H t η H , α θ H + β 1 γ θ H π 2

I 4is the 4 × 4 identity matrix.

Matrix (4A) is similar to the following matrix (details available upon request):

(5A) 1 0 0 0 0 0 1 0 0 0 J 3,1 J 3,2 δ P t η P , β θ P + β γ θ P + 1 + δ P t η P , α θ P + β γ θ P π 2 δ P t η P , β β 1 γ θ H + δ P t η P , α β 1 γ θ H π 2 δ P t η P , α β γ θ P β P + 1 γ θ H β H + β P π J 4,1 J 4,2 δ H t η H , α η P , β η P , α β γ θ P + δ H t η H , α β γ θ P π 2 δ H t η H , α η P , β η P , α θ H + β 1 γ θ H + 1 + δ H t η H , α θ H + β 1 γ θ H π 2 δ H t η H , α γ θ P β P + 1 γ θ H β H + β H π J 5,1 J 5,2 η P , β η P , α π γ θ P j = 1 4 J j , 1 γ θ P π j = 1 4 J j , 2 η P , β η P , α π 1 γ θ H j = 1 4 J j , 3 1 γ θ H π j = 1 4 J j , 4 β H 1 γ θ H + β P γ θ P

Hence, matrices (4A) and (5A) above have the same eigenvalues.

Matrix (5A) is clearly decomposable into the “north-west” 2 × 2 block and the “south-east” 3 × 3 block. Therefore, the eigenvalues of the matrix are those of the north-west block, the 2 × 2 identity matrix, plus the those of the 3 × 3 south-east block. This explains why the six elements of the 3 × 2 south-west block are not reported explicitly, being irrelevant for our purposes.

It follows that two eigenvalues of the Jacobian matrix of system (3A) are equal to one, and the remaining three eigenvalues are those of the south-east block of (5A). The presence of two unitary eigenvalues is equivalent to the existence of a two-dimensional continuum of SEs: if a SE is perturbed exactly in the direction of another SE, there will follow neither convergence to nor divergence from the new SE. As regards the remaining eigenvalues, scrutinizing matrix (5A) we suggest that:

  1. an increase of π SE (necessarily associated to a decrease in s SE) tends to increase the absolute value of the elements of (5A);

  2. the same tendency is induced by an increase in β, that, however, depresses π SE, as shown by the relevant derivative provided above;

  3. a similar effect is due to increases in the precision hyperparameters η i,α and η i,β ;

  4. given that subpopulation P bears lower vaccination costs (θ P < θ H ), an increase in γ tends to increase the absolute value of the elements of (5A).

These changes tend to push in the direction of an increase in the absolute value of the last three eigenvalues, which implies slower convergence or emphasized divergence, as shown in Figure 5.

References

Agranov, M., M. Elliott, and P. Ortoleva. 2021. “The Importance of Social Norms against Strategic Effects: The Case of Covid-19 Vaccine Uptake.” Economics Letters 206: 109979. https://doi.org/10.1016/j.econlet.2021.109979.Search in Google Scholar

Aquino, F., G. Donzelli, E. De Franco, G. Privitera, P. L. Lopalco, and A. Carducci. 2017. “The Web and Public Confidence in MMR Vaccination in Italy.” Vaccine 35: 4494–4498, https://doi.org/10.1016/j.vaccine.2017.07.029.Search in Google Scholar

Battiston, P., and M. Menegatti. 2023. “Interaction in Prevention: A General Theory and an Application to Covid-19 Pandemic.” The Geneva Risk and Insurance Review: 1–27. https://doi.org/10.1057/s10713-023-00092-3.Search in Google Scholar

Bauch, C. T. 2005. “Imitation Dynamics Predict Vaccinating Behaviour.” Proceedings of the Royal Society B: Biological Sciences 272: 1669–75. https://doi.org/10.1098/rspb.2005.3153.Search in Google Scholar

Bauch, C. T., and D. J. D. Earn. 2004. “Vaccination and the Theory of Games.” Proceedings of the National Academy of Sciences 101: 13391–4. https://doi.org/10.1073/pnas.0403823101.Search in Google Scholar

Becchetti, L., P. Candio, and F. Salustri. 2021. “Vaccine Uptake and Constrained Decision Making: The Case of Covid-19.” Social Science & Medicine 289: 114410. https://doi.org/10.1016/j.socscimed.2021.114410.Search in Google Scholar

Bhattacharyya, S., and C. T. Bauch. 2010. “A Game Dynamic Model for Delayer Strategies in Vaccinating Behaviour for Paediatric Infectious Diseases.” Journal of Theoretical Biology 267: 276–82. https://doi.org/10.1016/j.jtbi.2010.09.005.Search in Google Scholar

Bhattacharyya, S., A. Vutha, A. Lloyd, and C. T. Bauch. 2019. “The Impact of Rare but Severe Vaccine Adverse Events on Behaviour-Disease Dynamics: A Network Model.” Scientific Reports 9: 1–13. https://doi.org/10.1038/s41598-019-43596-7.Search in Google Scholar

Bigaard, J., and S. Franceschi. 2021. “Vaccination against HPV: Boosting Coverage and Tackling Misinformation.” Molecular Oncology 15: 770–8. https://doi.org/10.1002/1878-0261.12808.Search in Google Scholar

Campanozzi, L. L., V. Tambone, and M. Ciccozzi. 2022. “A Lesson from the Green Pass Experience in Italy: A Narrative Review.” Vaccines 10 (9): 1483. https://doi.org/10.3390/vaccines10091483.Search in Google Scholar

Chang, Sheryl L., Mahendra Piraveenan, Philippa Pattison, and Mikhail Prokopenko. 2020. “Game Theoretic Modelling of Infectious Disease Dynamics and Intervention Methods: a Review.” Journal of Biological Dynamics 14: 57–89. https://doi.org/10.1080/17513758.2020.1720322.Search in Google Scholar

Charrier, L., J. Garlasco, R. Thomas, P. Gardois, M. Bo, and C. M. Zotti. 2022. “An Overview of Strategies to Improve Vaccination Compliance before and during the COVID-19 Pandemic.” International Journal of Environmental Research and Public Health 19: 11044. https://doi.org/10.3390/ijerph191711044.Search in Google Scholar

Chen, F., and R. Stevens. 2017. “Applying Lessons from Behavioral Economics to Increase Flu Vaccination Rates.” Health Promotion International 32: 1067–73. https://doi.org/10.1093/heapro/daw031.Search in Google Scholar

Coelho, F., and C. T. Codeço. 2009. “Dynamic Modeling of Vaccinating Behavior as a Function of Individual Beliefs.” PLoS Computational Biology 5: e1000425. https://doi.org/10.1371/journal.pcbi.1000425.Search in Google Scholar

Dari-Mattiacci, G., and G. DeGeest. 2017. “Carrots vs. Sticks.” The Oxford Handbook of Law and Economics 1: 439–465.10.1093/oxfordhb/9780199684267.013.41Search in Google Scholar

De Figueiredo, A., H. J. Larson, and S. D. Reicher. 2021. “The Potential Impact of Vaccine Passports on Inclination to Accept COVID-19 Vaccinations in the United Kingdom: Evidence from a Large Cross-Sectional Survey and Modeling Study.” EClinicalMedicine 40: 101109, https://doi.org/10.1016/j.eclinm.2021.101109.Search in Google Scholar

De Figueiredo, A., H. J. Larson, E. Karafllakis, and M. Rawal. 2018. State of Vaccine Confidence in the EU 2018 European Commission Report. Also available at: https://health.ec.europa.eu/system/files/2018-11/2018_vaccine_confidence_en_0.pdf.Search in Google Scholar

De Geest, G., and G. Dari-Mattiacci. 2013. “The Rise of Carrots and the Decline of Sticks.” University of Chicago Law Review: 341–93.Search in Google Scholar

De Groot, M. H. 1970. Optimal Statistical Decisions. New York: McGraw-Hill Book Company.Search in Google Scholar

Dekel, E., D. Fudenberg, and K. Levine. 2004. “Learning to Play Bayesian Games.” Games and Economic Behavior 46: 282–303.10.1016/S0899-8256(03)00121-0Search in Google Scholar

Dhaliwal, D., and C. Mannion. 2020. “Antivaccine Messages on Facebook: Preliminary Audit.” JMIR Public Health and Surveillance 6: 18878. https://doi.org/10.2196/18878.Search in Google Scholar

D’Onofrio, A., and P. Manfredi. 2020. “The Interplay between Voluntary Vaccination and Reduction of Risky Behavior: a General Behavior-Implicit SIR Model for Vaccine Preventable Infections.” In Current Trends in Dynamical Systems in Biology and Natural Sciences, 185–203.10.1007/978-3-030-41120-6_10Search in Google Scholar

Donadel, M., M. S. Panero, L. Ametewee, and A. M. Shefer. 2021. “National Decision-Making for the Introduction of New Vaccines: A Systematic Review, 2010—2020.” Vaccine 39: 1897–909. https://doi.org/10.1016/j.vaccine.2021.02.059.Search in Google Scholar

Dubé, E., D. Gagnon, E. Nickels, S. Jeram, and M. Schuster. 2014. “Mapping Vaccine Hesitancy. Country-specific Characteristics of a Global Phenomenon.” Vaccine 32: 6649–54. https://doi.org/10.1016/j.vaccine.2014.09.039.Search in Google Scholar

Duclos, P., J. M. Okwo-Bele, M. Gacic-Dobo, and T. Cherian. 2009. “Global Immunization: Status, Progress, Challenges and Future.” BMC International Health and Human Rights 9: 1–11. https://doi.org/10.1186/1472-698x-9-s1-s2.Search in Google Scholar

Eaton, J. W., D. Bateman, S. Hauberg, and R. Wehbring. 2023. GNU Octave Version 8.4.0 Manual: A High-Level Interactive Language for Numerical Computations. Also available at: https://www.gnu.org/software/octave/doc/v8.4.0/.Search in Google Scholar

Ezekiel, M. 1938. “The Cobweb Theorem.” Quarterly Journal of Economics 52 (2): 255–80. https://doi.org/10.2307/1881734.Search in Google Scholar

Fabbri, M., and S. Hoeppner. 2018. “Compliance Externalities and the Role-Model Effect on Law Abidance: Field and Survey Experimental Evidence.” Journal of Empirical Legal Studies 15 (3): 539–62. https://doi.org/10.1111/jels.12185.Search in Google Scholar

Fine, P. E. M., and J. A. Clarkson. 1986. “Individual versus Public Priorities in the Determination of Optimal Vaccination Policies.” American Journal of Epidemiology 124: 1012–20. https://doi.org/10.1093/oxfordjournals.aje.a114471.Search in Google Scholar

Fluet, C., and M. C. Mungan. 2022. “Laws and Norms with (Un) Observable Actions.” European Economic Review 145: 104129. https://doi.org/10.1016/j.euroecorev.2022.104129.Search in Google Scholar

Francis, P. J. 1997. “Dynamic Epidemiology and the Market for Vaccinations.” Journal of Public Economics 63: 383–406. https://doi.org/10.1016/s0047-2727(96)01586-1.Search in Google Scholar

Fudenberg, D., and D. K. Levine. 1993. “Self-Confirming Equilibrium.” Econometrica 61: 523–545.10.2307/2951716Search in Google Scholar

Fukuda, E. 2015. “Pandemic Analysis and Evolutionary Games.” In Fundamentals of Evolutionary Game Theory and its Applications, 2015, 183–209. Springer.10.1007/978-4-431-54962-8_6Search in Google Scholar

Galvani, A. P., T. C. Reluga, and G. B. Chapman. 2007. “Long-standing Influenza Vaccination Policy Is in Accord with Individual Self-Interest but Not with the Utilitarian Optimum.” Proceedings of the National Academy of Sciences 104: 5692–7. https://doi.org/10.1073/pnas.0606774104.Search in Google Scholar

Gandolfo, G. 1980. Economic Dynamics: Methods and Models. Amsterdam: North-Holland.Search in Google Scholar

Geoffard, P-Y., and T. Philipson. 1997. “Disease Eradication: Public vs. Private Vaccination.” The American Economic Review 87 (1): 222–30.Search in Google Scholar

González-Block, M. Á., E. Gutiérrez-Calderón, B. E. Pelcastre-Villafuerte, J. Arroyo-Laguna, Y. Comes, P. Crocco, Andréa Fachel-Leal, et al.. 2020. “Influenza Vaccination Hesitancy in Five Countries of South America. Confidence, Complacency and Convenience as Determinants of Immunization Rates.” PLoS One 15 (12): e0243833. https://doi.org/10.1371/journal.pone.0243833.Search in Google Scholar

Gravagna, K., A. Becker, R. Valeris-Chacin, I. Mohammed, S. Tambe, F. A. Awan, T. L. Toomey, and N. E. Basta. 2020. “Global Assessment of National Mandatory Vaccination Policies and Consequences of Non-compliance.” Vaccine 38: 7865–73. https://doi.org/10.1016/j.vaccine.2020.09.063.Search in Google Scholar

Gualano, M. R., E. Olivero, G. Voglino, M. Corezzi, P. Rossello, C. Vicentini, F. Bert, and R. Siliquini. 2019. “Knowledge, Attitudes and Beliefs towards Compulsory Vaccination: A Systematic Review.” Human Vaccines & Immunotherapeutics 15: 918. https://doi.org/10.1080/21645515.2018.1564437.Search in Google Scholar

Hahn, F. H. 1977. “Exercises in Conjectural Equilibria.” The Scandinavian Journal of Economics 79: 210–226.10.2307/3439508Search in Google Scholar

Hethcote, H. W., and P. Waltman. 1973. “Optimal Vaccination Schedules in a Deterministic Epidemic Model.” Mathematical Biosciences 18: 365–81. https://doi.org/10.1016/0025-5564(73)90011-4.Search in Google Scholar

Hommes, C. H. 1994. “Dynamics of the Cobweb Model with Adaptive Expectations and Nonlinear Supply and Demand.” Journal of Economic Behavior & Organization 24 (3): 315–35. https://doi.org/10.1016/0167-2681(94)90039-6.Search in Google Scholar

Hommes, Cars, and Gerhard Sorger. 1998. “Consistent Expectations Equilibria.” Macroeconomic Dynamics 2 (3): 287–321. https://doi.org/10.1017/s1365100598008013.Search in Google Scholar

Hommes, C., J. Sonnemans, J. Tuinstra, and H. Van De Velden. 2007. “Learning in Cobweb Experiments.” Macroeconomic Dynamics 11 (S1): 8–33. https://doi.org/10.1017/s1365100507060208.Search in Google Scholar

Honkanen, P. O., T. Keistinen, and S. L. Kivela. 1996. “Factors Associated with Influenza Vaccination Coverage Among the Elderly: Role of Health Care Personnel.” Public Health 110: 163–8. https://doi.org/10.1016/s0033-3506(96)80070-9.Search in Google Scholar

Jolley, D., and K. M. Douglas. 2014. “The Effects of Anti-vaccine Conspiracy Theories on Vaccination Intentions.” PLoS One 9 (2): e89177. https://doi.org/10.1371/journal.pone.0089177.Search in Google Scholar

Lanza-León, P., D. Cantarero-Prieto, and M. Pascual-Sáez. 2024. “Exploring Trends and Determinants of Basic Childhood Vaccination Coverage: Empirical Evidence over 41 Years.” PLoS One 19 (3): e0300404. https://doi.org/10.1371/journal.pone.0300404.Search in Google Scholar

MacDonald, N. E., and SAGE Working Group on Vaccine Hesitancy. 2015. “Vaccine Hesitancy: Definition, Scope and Determinants.” Vaccine 33: 4161–4. https://doi.org/10.1016/j.vaccine.2015.04.036.Search in Google Scholar

Mantel, C., and T. Cherian. 2020. “New Immunization Strategies: Adapting to Global Challenges.” Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 63 (1): 25–31. https://doi.org/10.1007/s00103-019-03066-x.Search in Google Scholar

Nandi, A., and A. Shet. 2020. “Why Vaccines Matter: Understanding the Broader Health, Economic, and Child Development Benefits of Routine Vaccination.” Human Vaccines & Immuno-Therapeutics 16 (8): 1900–4. https://doi.org/10.1080/21645515.2019.1708669.Search in Google Scholar

Nerlove, M. 1958. “Adaptive Expectations and Cobweb Phenomena.” The Quarterly Journal of Economics 72 (2): 227–40. https://doi.org/10.2307/1880597.Search in Google Scholar

Odone, A., G. Dallagiacoma, B. Frascella, C. Signorelli, and J. Leask. 2021. “Current Understandings of the Impact of Mandatory Vaccination Laws in Europe.” Expert Review of Vaccines 20: 559–75. https://doi.org/10.1080/14760584.2021.1912603.Search in Google Scholar

Ozawa, S., A. Portnoy, H. Getaneh, S. Clark, M. Knoll, D. Bishai, H. Keri Yang, and P. D. Patwardhan. 2016. “Modeling the Economic Burden of Adult Vaccine-Preventable Diseases in the United States.” Health Affairs 35 (11): 2124–32. https://doi.org/10.1377/hlthaff.2016.0462.Search in Google Scholar

Paul, K. T., and K. Loer. 2019. “Contemporary Vaccination Policy in the European Union: Tensions and Dilemmas.” Journal of Public Health Policy 40: 166–79. https://doi.org/10.1057/s41271-019-00163-8.Search in Google Scholar

Posner, R. A. 1997. “Social Norms and the Law: An Economic Approach.” American Economic Review 87 (2): 365.Search in Google Scholar

Privor-Dumm, L., P. Vasudevan, K. Kobayashi, and J. Gupta. 2020. “Archetype Analysis of Older Adult Immunization Decision-Making and Implementation in 34 Countries.” Vaccine 38 (26): 4170–82. https://doi.org/10.1016/j.vaccine.2020.04.027.Search in Google Scholar

Rampa, G., and M. Saraceno. 2016. “Beliefs, Precedent, and the Dynamics of Access to Justice: A Bayesian Microfounded Model.” American Law and Economics Review 18 (2): 272–301. https://doi.org/10.1093/aler/ahw010.Search in Google Scholar

Rampa, G., and M. Saraceno. 2023. “Conjectures and Underpricing in Repeated Mass Disputes with Heterogeneous Plaintiffs.” Journal of Economics 139 (1): 1–32. https://doi.org/10.1007/s00712-022-00810-x.Search in Google Scholar

Reñosa, M. D. C., J. Landicho, J. Wachinger, S. L. Dalglish, K. Bärnighausen, T. Bärnighausen, and S. McMahon. 2021. “Nudging toward Vaccination: a Systematic Review.” BMJ Global Health 6: e006237. https://doi.org/10.1136/bmjgh-2021-006237.Search in Google Scholar

Sharun, K., R. Tiwari, K. Dhama, A. A. Rabaan, and S. Alhumaid. 2021. “COVID-19 Vaccination Passport: Prospects, Scientific Feasibility, and Ethical Concerns.” Human Vaccines & Immunotherapeutics 17 (11): 4108–11. https://doi.org/10.1080/21645515.2021.1953350.Search in Google Scholar

Shim, E., B. Kochin, and A. Galvani. 2009. “Insights from Epidemiological Game Theory into Gender-specific Vaccination against Rubella.” Mathematical Biosciences and Engineering 6: 839–54. https://doi.org/10.3934/mbe.2009.6.839.Search in Google Scholar

Shim, E., J. J. Grefenstette, S. M. Albert, B. E. Cakouros, and D. S. Burke. 2012a. “A Game Dynamic Model for Vaccine Skeptics and Vaccine Believers: Measles as an Example.” Journal of Theoretical Biology 295: 194–203. https://doi.org/10.1016/j.jtbi.2011.11.005.Search in Google Scholar

Shim, E., G. B. Chapman, J. P. Townsend, and A. P. Galvani. 2012b. “The Influence of Altruism on Influenza Vaccination Decisions.” Journal of the Royal Society Interface 9: 2234–43. https://doi.org/10.1098/rsif.2012.0115.Search in Google Scholar

Silver, M. C., P. J. Neumann, S. Ma, D. D. Kim, J. T. Cohen, M. Nyaku, Craig Roberts, Anushua Sinha, and D. A. Ollendorf. 2021. “Frequency and Impact of the Inclusion of Broader Measures of Value in Economic Evaluations of Vaccines.” Vaccine 39 (46): 6727–34. https://doi.org/10.1016/j.vaccine.2021.09.070.Search in Google Scholar

Siram, B., M. Shah, and R. Panda. 2022. “Vaccine Hesitancy in COVID-19: A Behavioural Economics Approach—A Systematic Literature Review.” Studies in Microeconomics 2022. https://doi.org/10.1177/23210222221129445.Search in Google Scholar

Standaert, B., C. Sauboin, R. DeAntonio, A. Marijam, J. Gomez, L. Varghese, and S. Zhang. 2020. “How to Assess for the Full Economic Value of Vaccines? from Past to Present, Drawing Lessons for the Future.” Journal of Market Access & Health Policy 8 (1): 1719588. https://doi.org/10.1080/20016689.2020.1719588.Search in Google Scholar

Stringham, E. P. 2011. “Embracing Morals in Economics: The Role of Internal Moral Constraints in a Market Economy.” Journal of Economic Behavior & Organization 78 (1–2): 98. https://doi.org/10.1016/j.jebo.2010.12.011.Search in Google Scholar

Szucs, T. 2000. “Cost--benefits of Vaccination Programmes.” Vaccine 18: S49–S51, https://doi.org/10.1016/s0264-410x(99)00464-8.Search in Google Scholar

Tafuri, S., M. S. Gallone, M. G. Cappelli, D. Martinelli, R. Prato, and C. Germinario. 2014. “Addressing the Anti-vaccination Movement and the Role of HCWs.” Vaccine 32: 4860–5. https://doi.org/10.1016/j.vaccine.2013.11.006.Search in Google Scholar

Tor, A. 2022. “The Law and Economics of Behavioral Regulation.” Review of Law & Economics 18: 223–81. https://doi.org/10.1515/rle-2021-0081.Search in Google Scholar

Vakili, R., A. Ghazizadeh Hashemi, G. Khademi, M. Ajilian Abbasi, and M. Saeidi. 2015. “Immunization Coverage in WHO Regions: A Review Article.” International Journal of Pediatrics 3 (2.1): 111–8.Search in Google Scholar

Van Winden, F., and E. Ash. 2012. “On the Behavioral Economics of Crime.” Review of Law & Economics 8: 181–213, https://doi.org/10.1515/1555-5879.1591.Search in Google Scholar

Vaz, O. M., M. K. Ellingson, P. Weiss, S. M. Jenness, A. Bardají, R. A. Bednarczyk, and S. B. Omer. 2020. “Mandatory Vaccination in Europe.” Pediatrics 145: e20190620, https://doi.org/10.1542/peds.2019-0620.Search in Google Scholar

Vrdelja, M., V. Učakar, and A. Kraigher. 2020. “From Mandatory to Voluntary Vaccination: Intention to Vaccinate in the Case of Policy Changes.” Public Health 180: 57–63, https://doi.org/10.1016/j.puhe.2019.10.026.Search in Google Scholar

Yaqub, O., S. Castle-Clarke, N. Sevdalis, and J. Chataway. 2014. “Attitudes to Vaccination: A Critical Review.” Social Science & Medicine 112: 1–11. https://doi.org/10.1016/j.socscimed.2014.04.018.Search in Google Scholar

Received: 2023-12-19
Accepted: 2024-07-31
Published Online: 2024-12-04

© 2024 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/rle-2023-0121/html
Scroll to top button